comparemela.com

Latest Breaking News On - Richardj mark - Page 6 : comparemela.com

Sempra (NYSE:SRE) Shares Sold by Quadrant Capital Group LLC

Quadrant Capital Group LLC cut its holdings in Sempra (NYSE:SRE – Free Report) by 3.7% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 6,387 shares of the utilities provider’s stock after selling 243 shares during the period. Quadrant Capital Group LLC’s holdings in Sempra were […]

Truist Financial Reiterates Buy Rating for Tenet Healthcare (NYSE:THC)

Truist Financial reaffirmed their buy rating on shares of Tenet Healthcare (NYSE:THC – Free Report) in a report published on Wednesday, Benzinga reports. They currently have a $130.00 target price on the stock, up from their prior target price of $120.00. A number of other brokerages also recently commented on THC. Wells Fargo & Company […]

Royal Bank of Canada Raises Tenet Healthcare (NYSE:THC) Price Target to $136 00

Tenet Healthcare (NYSE:THC – Free Report) had its target price lifted by Royal Bank of Canada from $109.00 to $136.00 in a report released on Wednesday morning, Benzinga reports. Royal Bank of Canada currently has an outperform rating on the stock. THC has been the subject of a number of other reports. UBS Group upped […]

Tenet Healthcare (NYSE:THC) Given Buy Rating at Mizuho

Mizuho reissued their buy rating on shares of Tenet Healthcare (NYSE:THC – Free Report) in a report released on Wednesday, Benzinga reports. The brokerage currently has a $130.00 price target on the stock, up from their previous price target of $118.00. A number of other analysts also recently weighed in on THC. Stephens increased their […]

Tenet Healthcare s (THC) Buy Rating Reaffirmed at Mizuho

Mizuho restated their buy rating on shares of Tenet Healthcare (NYSE:THC – Free Report) in a research report sent to investors on Wednesday, Benzinga reports. Mizuho currently has a $130.00 target price on the stock, up from their prior target price of $118.00. Several other research analysts have also issued reports on the company. Wolfe […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.